Microbiological spectrum of organisms in patients undergoing external ventricular drain insertion at a tertiary care

Mahrukh Afreen1, Syed Vaqar Hussain1, Aleezay Irfan2

  • 1Department of Neurosurgery, Shifa International Hospital.

Abstract

Insights

External ventricular drain infections occurred in 16.2% of patients, associated with poorer outcomes and longer hospital stays. Aseptic placement and early removal of external ventricular drains can help prevent these infections.

Area of Science:

  • Neurosurgery
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • External ventricular drains (EVDs) are crucial for managing cerebrospinal fluid (CSF) issues.
  • EVD-related infections pose significant risks to patient recovery and prognosis.
  • Understanding the incidence and impact of EVD infections is vital for improving patient care.

Purpose of the Study:

  • To determine the incidence of external ventricular drain-related infections.
  • To identify causative pathogens and their antibiotic sensitivities.
  • To assess the impact of EVD infections on patient outcomes.

Main Methods:

  • An observational, cross-sectional study was conducted with 74 patients undergoing EVD insertion.
  • Patients with prior CSF infections were excluded.
  • EVD-related infection was defined by positive CSF cultures post-insertion; data analyzed using SPSS 26.

Main Results:

  • The incidence of EVD-related infection was 16.2%, with coagulase-negative Staphylococcus epidermidis being the most common pathogen.
  • Infections were associated with significantly longer intensive care unit and hospital stays, and prolonged EVD in-situ duration.
  • No significant etiological risk factors for EVD infection were identified (p>0.05).

Conclusions:

  • EVD-related infections are linked to adverse patient outcomes, including extended hospital stays.
  • Preventive measures such as aseptic EVD placement and timely removal are recommended.
  • Effective antibiotic management, guided by culture sensitivity, is crucial for treating identified pathogens.